Gynesonics has filed a notice of an exempt offering of securities to raise $49,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Gynesonics is raising $49,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Louis Baldino played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Gynesonics
At Gynesonics our mission is to design and develop new and advanced technologies for improving womens health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids.
To learn more about Gynesonics, visit http://www.gynesonics.com/
Contact:
Louis Baldino, Chief Executive Officer
650-216-3860
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.